info icon

This is a non-core endpoint: only basic statistics are computed.

Butylpyrazolidines

RX_BUTYLPYRA

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Medicine purchases: ATC M01AA

1 out of 7 registries used, show all original rules.

22

4. Check minimum number of events

Min. number of events 3
22

5. Include endpoints

None

22

6. Filter based on genotype QC (FinnGen only)

22

Control definitions (FinnGen only)

Control exclude
RX_NSAID

Extra metadata

First used in FinnGen datafreeze
DF4

Case counts by codes

FinnGen case counts by registry codes:

Not enough data for upset plot.

Full data table

Summary Statistics

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 22 8 14
Unadjusted period prevalence (%) 0.00 0.00 0.01
Median age at first event (years) 46.95 41.83 49.88

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

No data available

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
13
59
3.92
2.54
8.8
5.7
—
—
—
0
0
10
45
3.24
1.79
3.6
2.2
—
—
—
0
0
16
103
3.02
1.60
6.3
4.2
—
—
—
0
0
10
51
2.76
1.38
2.3
3.8
—
—
—
0
0
5
18
3.28
1.36
2.2
1.5
—
—
—
0
0
5
18
3.28
1.36
1.2
1.1
—
—
—
0
0
6
25
2.91
1.35
1.8
3.4
—
—
—
0
0
16
114
2.47
1.13
4.3
3.2
15.0
15.4
pmol/l
0.32
16
102
7
40
2.09
0.81
7.4
7.3
—
—
—
0
0
8
52
1.84
0.70
2.4
2.3
—
—
—
0
0
0
20
0.00
0.64
0.0
2.1
—
433.0
—
0
20
11
79
1.78
0.55
17.1
13.6
—
1.4
—
0
26
5
35
1.55
0.42
2.8
3.1
12.0
2223.2
ng/l
—
5
29
0
17
0.00
0.42
0.0
8.5
—
24.8
—
0
17
13
113
1.37
0.29
3.5
4.1
—
—
—
0
0
6
47
1.38
0.23
5.3
4.9
—
—
—
0
0
0
11
0.00
0.22
0.0
12.2
—
94.5
—
0
11
0
10
0.00
0.22
0.0
3.2
—
—
—
0
0
0
10
0.00
0.22
0.0
6.4
—
—
—
0
0
0
10
0.00
0.22
0.0
3.0
—
24.2
—
0
10
0
10
0.00
0.22
0.0
2.4
—
1.1
—
0
10
0
10
0.00
0.22
0.0
2.4
—
0.7
—
0
10
7
58
1.30
0.21
1.9
4.1
—
—
—
0
0
0
14
0.00
0.21
0.0
3.7
—
15.3
—
0
14
0
14
0.00
0.21
0.0
1.6
—
—
—
0
0
15
137
1.30
0.19
26.5
22.2
330.1
330.6
g/l
0.12
15
137
5
47
1.08
0.10
4.6
5.5
—
—
—
0
0
15
139
1.25
0.09
24.1
19.9
41.7
36.4
%
—
10
94
0
7
0.00
0.00
0.0
2.6
—
—
—
0
0
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
5
51
0.97
0.00
2.4
1.6
1.5
1.3
mmol/l
—
5
42
0
5
0.00
0.00
0.0
7.4
—
—
—
0
0
0
5
0.00
0.00
0.0
3.4
—
103.8
—
0
5
0
5
0.00
0.00
0.0
1.4
—
1.5
—
0
5
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
5
55
0.88
0.00
1.0
4.8
2.2
2.3
mmol/l
—
5
50
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
5
54
0.90
0.00
2.8
3.4
—
—
—
0
0
0
5
0.00
0.00
0.0
3.4
—
4.3
—
0
5
5
50
1.00
0.00
5.0
2.8
—
—
—
0
0
5
57
0.84
0.00
8.8
5.3
—
7.4
—
0
11
0
6
0.00
-0.00
0.0
2.2
—
7.4
—
0
6
0
8
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
2.5
—
7.5
—
0
8
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.8
—
4.8
—
0
6
0
6
0.00
-0.00
0.0
1.8
—
3.0
—
0
6
0
6
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
8
0.00
-0.00
0.0
3.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.8
—
8.1
—
0
6

Mortality – FinRegistry

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

Index endpoint: RX_BUTYLPYRA – Butylpyrazolidines

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).